1. Home
  2. BKU vs GKOS Comparison

BKU vs GKOS Comparison

Compare BKU & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BankUnited Inc.

BKU

BankUnited Inc.

HOLD

Current Price

$44.65

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$114.79

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BKU
GKOS
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
5.4B
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
BKU
GKOS
Price
$44.65
$114.79
Analyst Decision
Hold
Strong Buy
Analyst Count
11
13
Target Price
$42.73
$126.38
AVG Volume (30 Days)
850.5K
697.5K
Earning Date
01-21-2026
02-19-2026
Dividend Yield
2.76%
N/A
EPS Growth
44.85
N/A
EPS
3.54
N/A
Revenue
$1,016,093,000.00
$469,820,000.00
Revenue This Year
$14.68
$31.15
Revenue Next Year
$5.82
$24.15
P/E Ratio
$12.68
N/A
Revenue Growth
10.45
30.38
52 Week Low
$28.21
$73.16
52 Week High
$46.92
$163.71

Technical Indicators

Market Signals
Indicator
BKU
GKOS
Relative Strength Index (RSI) 56.53 67.78
Support Level $44.91 $115.07
Resistance Level $45.65 $117.94
Average True Range (ATR) 0.83 2.73
MACD -0.29 -0.46
Stochastic Oscillator 7.86 72.50

Price Performance

Historical Comparison
BKU
GKOS

About BKU BankUnited Inc.

BankUnited Inc is a bank holding company with one wholly owned subsidiary, BankUnited. The bank provides a full range of banking services through banking centers located throughout Florida, as well as New York City. The company is a commercially focused regional bank focusing on small and middle-market businesses, but also provides certain commercial lending and deposit products on a national platform. The Bank offers a comprehensive suite of commercial lending and deposit products through an Atlanta office focused on the Southeast region, certain commercial lending and deposit products through national platforms and certain consumer deposit products through an online channel.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: